Proxied CETP inhibition wasassociated with a reduced risk of AAA (OR: 0.127, 95% CI: 0.066–0.243,p< 0.0055), but no evidence of a protective effect was observed forTAA, AD and CAVS. Here, CETP is linked to triple-A syndrome.